Unhealthy Pharmaceutical Regulation
Innovation, Politics and Promissory Science
Series: Health, Technology and Society;
-
GET 12% OFF
- Publisher's listprice EUR 106.99
-
41 790 Ft (39 800 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 12% (cc. 5 015 Ft off)
- Discounted price 36 775 Ft (35 024 Ft + 5% VAT)
36 775 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 2013
- Publisher Palgrave Macmillan UK
- Date of Publication 8 November 2013
- Number of Volumes 1 pieces, Book
- ISBN 9780230008663
- Binding Hardback
- No. of pages321 pages
- Size 216x140 mm
- Weight 5219 g
- Language English
- Illustrations XII, 321 p. Tables, black & white 0
Categories
Long description:
This is the first book to examine how effectively American and supranational EU governments have regulated innovative pharmaceuticals during the last 30 years regarding public health. It explains why pharmaceutical regulation has been misdirected by commercial interests and misconceived ideologies.
MoreTable of Contents:
1. Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health 2. The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era 3. Designs on Diabetes Drugs 4. Desperate Regulation for Desperate Cancer Patients 5. The Making of a Harmful 'Therapeutic Breakthrough' 6. The Regulatory Science and Politics of Risk Management 7. Conclusions and Policy Implications
More
